Concepedia
Statistics
Publications
5
Citations
142
H-Index
Active since
2019
Affiliations
Inserm(Current)
Université Fédérale de Toulouse Midi-Pyrénées
Université Toulouse III - Paul Sabatier
Hôtel-Dieu de Paris
Centre Hospitalier Universitaire de Nantes
Robel Tesfaye is an author at Inserm specializing in medicine, molecular biology, and oncology.
Publications per year
2019–2023
Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
Mélanie Lavaud, Mathilde Mullard, Robel Tesfaye et al. · Cells · 2021 · 43 citations · Full text
Medicine, Molecular Biology, Oncology +17
The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
Sarah Morice, Mathilde Mullard, Régis Brion et al. · Cancers · 2020 · 41 citations · Full text
RPL13 Variants Cause Spondyloepimetaphyseal Dysplasia with Severe Short Stature
Cédric Le Caignec, Benjamin Ory, François Lamoureux et al. · The American Journal of Human Genetics · 2019 · 30 citations · Full text
Medicine, Genetics, Molecular Genetics +14
Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis
Sarah Morice, Geoffroy Danieau, Robel Tesfaye et al. · Frontiers in Oncology · 2021 · 16 citations · Full text
Medicine, Cancer Biology, Oncology +17
POLE3 is a repressor of unintegrated HIV-1 DNA required for efficient virus integration and escape from innate immune sensing
Suzie Thenin-Houssier, Shinichi Machida, Cyprien Jahan et al. · Science Advances · 2023 · 12 citations · Full text
Life Sciences, Genetics, Molecular Biology +17
1–5 of 5